Medicus Pharma Advances Teverelix Phase 2 FDA Strategy
Philadelphia, Pennsylvania, USA, April 6, 2026 Optimized Phase 2 Design Targets Faster Clinical Development In a strategic move to...
Interventional Cardiology
Advertisement
Egg Medical Launches EggNest Flex Apron-Free Protection
Minneapolis, Minnesota, USA, April 6, 2026 Breakthrough Radiation Protection Without Operational Disruption In a significant advancement for interventional cardiology...
Philips AI Gains FDA Clearance for Heart Valve Guidance
AMSTERDAM, Netherlands, March 26, 2026 Royal Philips announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
Haemonetics Secures FDA Nod for VASCADE MVP XL Expansion
BOSTON, March 30, 2026 In a significant advancement for interventional cardiology and electrophysiology procedures, Haemonetics Corporation announced that the...
Catheter Precision Showcases LockeT Device at ISLAA 2026
FORT MILL, S.C., March 6, 2026 Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations,...
Advertisements
Japan Grants Insurance Coverage for Paradise uRDN System
TOKYO, Japan – March 1, 2026 Otsuka Medical Devices Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced that the...
OMNY AF Study Shows Early Gains in AF Ablation
Boston, Massachusetts — February 6, 2026 Johnson & Johnson has presented early clinical outcomes from the OMNY AF Pilot...
Advertisement
